Inovio Pharmaceuticals Inc (NASDAQ:INO)

4.26
Delayed Data
As of 4:00pm ET
 -0.17 / -3.84%
Today’s Change
3.76
Today|||52-Week Range
8.44
+3.15%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$430.3M

Company Description

Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Contact Information

Inovio Pharmaceuticals, Inc.
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462-1111
P:(267) 440-4200
Investor Relations:
(484) 362-0076

Employees

Shareholders

Individual stakeholders6.36%
Mutual fund holders19.20%
Other institutional14.06%

Top Executives

J. Joseph KimPresident, Chief Executive Officer & Director
Niranjan Y. SardesaiChief Operating Officer
Peter D. KiesChief Financial Officer
Mark L. BagarazziChief Medical Officer
Laurent M. HumeauSenior Vice President-Research & Development